Charles Evans, DO
Pulmonary Disease · Jackson, MSNPI 1326335902
Payments from drug & device makers
Across 676 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$4K
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- Actelion Pharmaceuticals US, Inc.$984
- Sanofi$587
- Mallinckrodt Hospital Products Inc.$446
- plus $3K from 30 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 254 | $3,860 |
| AstraZeneca | 82 | $2,007 |
| Boehringer Ingelheim | 72 | $1,117 |
| Actelion Pharmaceuticals US, Inc. | 48 | $984 |
| Sanofi | 32 | $587 |
| Mallinckrodt Hospital Products Inc. | 22 | $446 |
| Mylan Specialty L.p. | 24 | $394 |
| Regeneron Healthcare Solutions, Inc. | 18 | $385 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $225 |
| Genentech USA, Inc. | 10 | $166 |
| Electromed, Inc. | 11 | $149 |
| Insmed, Inc. | 8 | $148 |
| Inari Medical, Inc. | 10 | $148 |
| Grifols USA, LLC | 9 | $144 |
| Verona Pharma, Inc. | 12 | $139 |
| Merck | 7 | $121 |
| AbbVie | 4 | $98 |
| Novartis | 6 | $85 |
| United Therapeutics Corporation | 5 | $82 |
| Gilead | 5 | $78 |
| 3b Medical, Inc. | 3 | $69 |
| Ambu Inc. | 2 | $54 |
| CSL Behring | 2 | $52 |
| Amgen | 3 | $45 |
| Sunovion Pharmaceuticals Inc. | 2 | $40 |
| Portola Pharmaceuticals, LLC | 2 | $32 |
| Viatris Specialty LLC | 1 | $27 |
| La Jolla Pharmaceutical Company | 2 | $25 |
| Philips North America LLC | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Boston Scientific | 1 | $17 |
| Bayer | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Pfizer | 1 | $11 |
How this compares
$11,841 in reported general payments places this provider in the 70th percentile of 101 pulmonary disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Jackson
- Demondes HaynesJackson$809K
- Michal SenitkoJackson$355K
- Andrew WilhelmJackson$164K
- Maria RappaiJackson$45K
- Raymond PortisJackson$39K
- Kimberly DobbsJackson$35K
- George AbrahamJackson$23K
- Arash SamarghandiJackson$19K
- Richard WellsJackson$19K
- Rajesh PatelJackson$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.